MercadoLibre and Eli Lilly Are Top Growth Stocks to Buy Now

Industry
โดย The Motley Fool·Read original
Summary · why it matters

MercadoLibre and Eli Lilly are highlighted as two top growth stocks to buy without hesitation. MercadoLibre is investing heavily in logistics and fulfillment to defend its Latin American e-commerce and fintech dominance against competitors like Amazon, Shein, and Temu, creating a buying opportunity amid a stock dip. Eli Lilly is capitalizing on soaring demand for its GLP-1 drugs Mounjaro and Zepbound, which drive roughly two-thirds of revenue and support a full-year forecast of $82 billion to $85 billion, while expanding manufacturing with a $4.5 billion facility investment and pursuing 10 acquisitions in 2026. Both companies offer long-term growth potential through market leadership and innovation.

Impact on stocks 5

Biotech & Genomic Medicine▲ · 2 stocks
Eli Lilly and Company
LLY
▲ PositiveDemandrelevance

Soaring demand for GLP-1 drugs Mounjaro and Zepbound drives revenue and growth.

Digital Finance & Tokenization▲ · 1 stocks
MercadoLibre Inc.
MELI
▲ PositiveCapitalrelevance

Investing heavily in logistics and fulfillment to defend dominance, creating a buying opportunity amid stock dip.

Artificial Intelligence▲ · 1 stocks
Consumer Discretionary▲ · 1 stocks
© 2026 MarketDXNews